Related Experiment Videos
Clinical syndromes of hormone receptor mutations: hormone resistance and independence
1Department of Endocrinology, Wilford Hall Medical Center, Lackland AFB, TX 78236.
Abstract:
Clinical syndromes of hormone resistance or independence have baffled clinicians for decades. These syndromes sometimes result from mutations or deficiencies in enzymes that activate prohormones or from alterations in signal transduction proteins. The majority of these conditions, however, arise from abnormalities of hormone receptors. We describe examples of syndromes that result from genetic mutations or misexpression of steroid/thyroid hormone receptors, with a specific emphasis on thyroid and androgen resistance syndromes, and estrogen independence in breast cancer.
Insights
Hormone resistance syndromes often stem from hormone receptor abnormalities. This study examines genetic mutations in steroid/thyroid hormone receptors, focusing on thyroid and androgen resistance, and estrogen independence in breast cancer.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Hormone resistance and independence syndromes present diagnostic challenges.
- These conditions can arise from enzyme deficiencies or altered signaling pathways.
- Most syndromes are linked to abnormalities in hormone receptors.
Purpose of the Study:
- To review clinical syndromes caused by genetic mutations or misexpression of steroid/thyroid hormone receptors.
- To emphasize thyroid and androgen resistance syndromes.
- To discuss estrogen independence in breast cancer.
Main Methods:
- Review of genetic mutations and misexpression in hormone receptors.
- Focus on specific case examples of resistance and independence syndromes.
Main Results:
- Genetic mutations and misexpression of steroid/thyroid hormone receptors are key causes of hormone resistance syndromes.
- Thyroid and androgen resistance syndromes exemplify these genetic alterations.
- Estrogen independence in breast cancer is also linked to receptor abnormalities.
Conclusions:
- Abnormalities in hormone receptors, particularly genetic mutations, are central to hormone resistance syndromes.
- Understanding these genetic underpinnings is crucial for clinical management.
- Further research into receptor function can elucidate complex endocrine disorders.